|
Gene sets significantly up-regulated after 7 days of medication (day 7). |
||||
| Rank |
Gene Sets – Up-regulated |
Size |
Nom P-value |
FDR (%) |
|
|
||||
| 1 |
Protein disulfide isomerase activity |
26 |
0.0 |
1.72 |
| 2 |
Intramolecular oxidoreductase activity, transposing S-S bonds |
26 |
0.0 |
0.86 |
| 3 |
Peptidyl-asparagine modification |
16 |
0.0 |
3.2 |
| 4 |
Protein amino acid N-linked glycosylation via asparagine |
16 |
0.0 |
2.4 |
| 5 |
Intramolecular oxidoreductase activity |
36 |
0.0 |
2.89 |
| 6 |
Protein localization |
37 |
0.0 |
11.7 |
| 7 |
Isomerase activity |
52 |
0.0 |
10.9 |
| 8 |
Peptidyl-amino acid modification |
23 |
0.0 |
10.79 |
| 9 |
Oligosaccharyl transferase complex |
19 |
0.0 |
10.66 |
|
Gene set enrichment analysis (GSEA) with a false discovery rate (FDR) cut-off of approximately 10%. Nominal P values are also shown, as well as gene set sizes (number of genes in each gene set). No gene sets were significantly down-regulated after 7 days of medication, with a FDR lower than about 10%. | ||||
Olsvik et al. BMC Pharmacology 2008 8:16 doi:10.1186/1471-2210-8-16 |
||||